InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
28
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Laponis Adam, Chief Financial Officer. Officer active across 2 companies, notably Eargo, Inc.. Cumulatively, 40 disclosures have been recorded. Breakdown: 0 buy · 28 sells. Total volume traded: €2.8m. History available since 17 May 2021. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Laponis Adam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
1,965 shares@ US$139.066Common StockSEC:0001214659-26-010829:0
2,399 shares@ US$94.3340.0030% mcap7.2% of flowCommon StockSEC:0001214659-26-008480:0
4,000 shares@ US$60.000.0031% mcap17.5% of flowCommon StockSEC:0001214659-26-004893:0
3,000 shares@ US$55.000.0021% mcap12.0% of flowCommon StockSEC:0001214659-26-004735:0
2,597 shares@ US$49.8898.7% of flowCommon StockSEC:0001214659-26-004601:0
2,085 shares@ US$46.70983.2% of flowCommon StockSEC:0001214659-26-002442:0
7,000 shares@ US$50.0011.6% of flowCommon StockSEC:0001214659-26-001737:0
3,000 shares@ US$40.004.0% of flowCommon StockSEC:0001214659-26-000509:0
2,738 shares@ US$35.2613.3% of flowCommon StockSEC:0001214659-26-000423:0
887 shares@ US$26.50351.0% of flowCommon StockSEC:0001214659-25-017219:0
32,648 shares0Common StockSEC:0001214659-25-017001:0
5,517 shares@ US$31.44437.6% of flowCommon StockSEC:0001214659-25-015763:0
25,000 shares0Common StockSEC:0001214659-25-015583:0
3,000 shares@ US$31.154.4% of flowCommon StockSEC:0001214659-25-014856:0
5,875 shares@ US$32.1879.3% of flowCommon StockSEC:0001214659-25-014777:0
918 shares@ US$25.9641.3% of flowCommon StockSEC:0001214659-25-012706:0
2,449 shares@ US$38.1465.9% of flowCommon StockSEC:0001214659-25-010310:0
936 shares@ US$29.7473.0% of flowCommon StockSEC:0001214659-25-008296:0
2,542 shares@ US$34.96749.9% of flowCommon StockSEC:0001214659-25-005780:0
918 shares@ US$44.1774.7% of flowCommon StockSEC:0001214659-25-003435:0
5,886 shares@ US$43.26330.2% of flowCommon StockSEC:0001214659-25-000554:0
26,745 shares0Common StockSEC:0001214659-24-020031:0
4,160 shares@ US$44.60520.7% of flowCommon StockSEC:0001214659-24-019254:0
4,160 shares@ US$44.60520.7% of flowCommon StockSEC:0001214659-24-018614:0
20,000 shares0Common StockSEC:0001214659-24-018498:0
25 of 40 declarations
About Laponis Adam
Laponis Adam is Chief Financial Officer. He has filed 39 disclosures in total. Across the 39 sampled filings, all reported transactions are sales, for a total of EUR 2555330, between 2021-05-19 and 2026-07-13. The recent filings concern Twist Bioscience Corp and Eargo, Inc., and the largest items in the sampled set are a sale of EUR 294710.4818405031 on 2026-02-13 at Twist Bioscience Corp and a sale of EUR 247286.7364794044 on 2025-01-14 at Twist Bioscience Corp.
